These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 22770610)
1. Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay. Rohe A; Göllner C; Wichapong K; Erdmann F; Al-Mazaideh GM; Sippl W; Schmidt M Eur J Med Chem; 2013 Mar; 61():41-8. PubMed ID: 22770610 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of glycoglycerolipid of 1,2-dipalmitoyl-3-(N-palmitoyl-6'-amino-6'-deoxy-α-D-glucosyl)-sn-glycerol and its analogues, inhibitors of human Myt1-kinase. Sun Y; Zhang J; Li C; Guan H; Yu G Carbohydr Res; 2012 Jul; 355():6-12. PubMed ID: 22578528 [TBL] [Abstract][Full Text] [Related]
3. The glycoglycerolipid 1,2-dipalmitoyl-3-(N-palmitoyl-6'-amino-6'-deoxy-α-d-glucosyl)-sn-glycerol is no inhibitor of the human Myt1 kinase. Rohe A; Göllner C; Erdmann F; Sippl W; Schmidt M J Enzyme Inhib Med Chem; 2015 Jun; 30(3):514-7. PubMed ID: 24939100 [TBL] [Abstract][Full Text] [Related]
4. First total synthesis of 1,2-dipalmitoyl-3-(N-palmitoyl-6'-amino-6'-deoxy-alpha-D-glucosyl)-sn-glycerol--a glycoglycerolipid of a marine alga with a high inhibitor activity against human Myt1-kinase. Göllner C; Philipp C; Dobner B; Sippl W; Schmidt M Carbohydr Res; 2009 Sep; 344(13):1628-31. PubMed ID: 19555926 [TBL] [Abstract][Full Text] [Related]
5. A fluorescence anisotropy-based Myt1 kinase binding assay. Rohe A; Henze C; Erdmann F; Sippl W; Schmidt M Assay Drug Dev Technol; 2014 Mar; 12(2):136-44. PubMed ID: 24229357 [TBL] [Abstract][Full Text] [Related]
6. Application of docking and QM/MM-GBSA rescoring to screen for novel Myt1 kinase inhibitors. Wichapong K; Rohe A; Platzer C; Slynko I; Erdmann F; Schmidt M; Sippl W J Chem Inf Model; 2014 Mar; 54(3):881-93. PubMed ID: 24490903 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation and molecular modelling studies of 4-anilinoquinazoline derivatives as protein kinase inhibitors. Waiker DK; Karthikeyan C; Poongavanam V; Kongsted J; Lozach O; Meijer L; Trivedi P Bioorg Med Chem; 2014 Mar; 22(6):1909-15. PubMed ID: 24530227 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of 6'-acylamido-6'-deoxy-α-D-galactoglycerolipids. Li C; Sun Y; Zhang J; Zhao Z; Yu G; Guan H Carbohydr Res; 2013 Jul; 376():15-23. PubMed ID: 23727703 [TBL] [Abstract][Full Text] [Related]
9. Identification of PKMYT1 inhibitors by screening the GSK published protein kinase inhibitor set I and II. Platzer C; Najjar A; Rohe A; Erdmann F; Sippl W; Schmidt M Bioorg Med Chem; 2018 Aug; 26(14):4014-4024. PubMed ID: 29941193 [TBL] [Abstract][Full Text] [Related]
10. Computer-aided design, synthesis and biological characterization of novel inhibitors for PKMYT1. Najjar A; Platzer C; Luft A; Aßmann CA; Elghazawy NH; Erdmann F; Sippl W; Schmidt M Eur J Med Chem; 2019 Jan; 161():479-492. PubMed ID: 30388464 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase. Rohe A; Erdmann F; Bäßler C; Wichapong K; Sippl W; Schmidt M Bioorg Med Chem Lett; 2012 Jan; 22(2):1219-23. PubMed ID: 22189141 [TBL] [Abstract][Full Text] [Related]
12. Computational & experimental evaluation of the structure/activity relationship of β-carbolines as DYRK1A inhibitors. Drung B; Scholz C; Barbosa VA; Nazari A; Sarragiotto MH; Schmidt B Bioorg Med Chem Lett; 2014 Oct; 24(20):4854-60. PubMed ID: 25240617 [TBL] [Abstract][Full Text] [Related]
13. Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides. Laufer R; Ng G; Liu Y; Patel NK; Edwards LG; Lang Y; Li SW; Feher M; Awrey DE; Leung G; Beletskaya I; Plotnikova O; Mason JM; Hodgson R; Wei X; Mao G; Luo X; Huang P; Green E; Kiarash R; Lin DC; Harris-Brandts M; Ban F; Nadeem V; Mak TW; Pan GJ; Qiu W; Chirgadze NY; Pauls HW Bioorg Med Chem; 2014 Sep; 22(17):4968-97. PubMed ID: 25043312 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro evaluation of diverse heterocyclic diphenolic compounds as inhibitors of DYRK1A. Zhou Q; Reekie TA; Abbassi RH; Indurthi Venkata D; Font JS; Ryan RM; Munoz L; Kassiou M Bioorg Med Chem; 2018 Dec; 26(22):5852-5869. PubMed ID: 30401502 [TBL] [Abstract][Full Text] [Related]
15. Functional characterization of peanut serine/threonine/tyrosine protein kinase: molecular docking and inhibition kinetics with tyrosine kinase inhibitors. Rudrabhatla P; Rajasekharan R Biochemistry; 2004 Sep; 43(38):12123-32. PubMed ID: 15379551 [TBL] [Abstract][Full Text] [Related]
16. A fluorescence resonance energy transfer-based binding assay for characterizing kinase inhibitors: important role for C-terminal biotin tagging of the kinase. Kwan J; Ling A; Papp E; Shaw D; Bradshaw JM Anal Biochem; 2009 Dec; 395(2):256-62. PubMed ID: 19716360 [TBL] [Abstract][Full Text] [Related]
18. Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors. Zhu JY; Cuellar RA; Berndt N; Lee HE; Olesen SH; Martin MP; Jensen JT; Georg GI; Schönbrunn E J Med Chem; 2017 Sep; 60(18):7863-7875. PubMed ID: 28792760 [TBL] [Abstract][Full Text] [Related]
19. Novel Mps1 kinase inhibitors: from purine to pyrrolopyrimidine and quinazoline leads. Bursavich MG; Dastrup D; Shenderovich M; Yager KM; Cimbora DM; Williams B; Kumar DV Bioorg Med Chem Lett; 2013 Dec; 23(24):6829-33. PubMed ID: 24183538 [TBL] [Abstract][Full Text] [Related]
20. A unique hinge binder of extremely selective aminopyridine-based Mps1 (TTK) kinase inhibitors with cellular activity. Kusakabe K; Ide N; Daigo Y; Itoh T; Yamamoto T; Kojima E; Mitsuoka Y; Tadano G; Tagashira S; Higashino K; Okano Y; Sato Y; Inoue M; Iguchi M; Kanazawa T; Ishioka Y; Dohi K; Kido Y; Sakamoto S; Ando S; Maeda M; Higaki M; Yoshizawa H; Murai H; Nakamura Y Bioorg Med Chem; 2015 May; 23(9):2247-60. PubMed ID: 25801152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]